Drug Database
Back to search

Canada· CA-DIN-02261219

HUMATE-P

A von willebrand-faktor und faktor viii in kombination product containing von willebrand factor (human) + antihemophilic factor (human), registered in Canada by CSL BEHRING CANADA INC. The same ATC class is registered in 11 of our 19 countries.

ATC B02BD06

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedHUMATE-PATCB02BD06REGISTER NO.CA-DIN-02261219PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about von willebrand factor (human) + antihemophilic factor (human)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Von willebrand-faktor und faktor viii in kombination is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BD06 (von willebrand-faktor und faktor viii in kombination), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose
Search von willebrand-faktor und faktor viii in kombination products by name

Von willebrand-faktor und faktor viii in kombination · ATC B02BD06

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
VON WILLEBRAND FACTOR (HUMAN) + ANTIHEMOPHILIC FACTOR (HUMAN)
Manufacturer
CSL BEHRING CANADA INC
Country
Canada (CA)
ATC code
B02BD06
ATC class
von Willebrand-Faktor und Faktor VIII in Kombination
Defined daily dose
1 TSD, E
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Von willebrand-faktor und faktor viii in kombination in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All von willebrand-faktor und faktor viii in kombination products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Haemate P, Immunate
  • Belgium · Haemate P, Wilate
  • Bulgaria · Wilate, Имунейт
  • Cyprus · Haemate P, Immunate
  • Czechia · Fanhdi, Haemate P
  • Germany · Haemate P, Immunate
  • Denmark · Haemate, Wilnativ
  • Estonia · Haemate, Immunate
  • Spain · Fanhdi, Haemate P
  • Finland · Haemate, Haemwill
  • France · Eqwilate
  • United Kingdom (Northern Ireland) · Alphanate, Dried Factor Viii Fraction Type 8y Bio Products Laboratory
  • Greece · Haemate P
  • Croatia · Fanhdi, Haemate P
  • Hungary · Haemate P, Immunate S/D
  • Ireland · Wilate
  • Iceland · Voncento
  • Italy · Alphanate, Fanhdi
  • Liechtenstein · Voncento
  • Lithuania · Haemate, Immunate
  • Luxembourg · Haemate P, Wilate
  • Latvia · Haemate, Immunate
  • Malta · Immunate, Wilate
  • Netherlands · Haemate P, Wilate
  • Norway · Haemate, Voncento
  • Poland · Fanhdi, Haemate P
  • Portugal · Haemate P, Immunate
  • Romania · Haemate P, Immunate
  • Sweden · Haemate, Wilate
  • Slovenia · Haemate P, Immunate
  • Slovakia · Fanhdi, Haemate P

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0e793d32-9766-464c-84eb-2120728384be
GET /v1/drugs/0e793d32-9766-464c-84eb-2120728384be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02261219",
  "form": "POWDER FOR SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B02BD06",
  "schedule": [
    "Schedule D"
  ],
  "drug_code": "74661",
  "strengths": [
    "840 UNIT",
    "300 UNIT"
  ],
  "ahfs_class": null,
  "substances": [
    "VON WILLEBRAND FACTOR (HUMAN)",
    "ANTIHEMOPHILIC FACTOR (HUMAN)"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about von willebrand-faktor und faktor viii in kombination.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console